Comparison of effects of natural or artificial rodent diet on etoposide absorption in rats

In Vivo

Volumn 13, Issue 1, 1999, Pages 51-55

  Lo, Yu Li ^a   Huang, Jin Ding ^b  

^a CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Etoposide; Everted sac; P glycoprotein; Quercetin; Rodent diet

Indexed keywords

ETOPOSIDE; GLYCOPROTEIN P; QUERCETIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET; DRUG ABSORPTION; DRUG BIOAVAILABILITY; ILEUM; JEJUNUM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0032896566     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Gottesman, MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 386-427, 1993.
2. Larocca LM, Piantelli M, Leone G, Sica S, Teofili L, Benedetti Panici P, Scambia G, Mancuso S, Capelli A, Ranelletti FO: Type II oestrogen binding sites in acute lymphoid and non-lymphoid leukaemia: growth inhibitory effect of oestrogen and flavonoids. Br J Haematol 75: 489-495, 1990.
3. Ranelletti FD, Ricci R, Larocca LM, Maggiano N, Capelli A, Scambia G, Benedetti Panici P, Mancuso S, Rum C, Piantelli M: Growth-inhibitory effect of quercetin and presence of type II oestrogen binding sites in human colorectal cell lines and primary colorectal tumours. Int J Cancer 50: 486-492, 1992.
4. Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina G, Rumi C, Larocca LM, Mancuso S: Inhibitory effect of quercetin on DVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumours and cultured cells. Br J Cancer 62: 942-946, 1990.
5. Scambia C, Ranelletti FO, Benedetti Panici P, Piantelli M, Rumi C, Battaglia F, Larocca LM, Capelli A, Mancuso S: Type II estrogen binding sites in a lymphoblastoid cell line and growth inhibitory effect of estrogen, antiestrogen and bioflavonoids. Int J Cancer 46: 1112-1116, 1990.
6. Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina G, Pierelli L, Capelli A, Mancuso S: Quercetin inhibits the growth of a multidrug resistant estrogen receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sites. Cancer Chemother Pharmacol 28: 255-258, 1991.
7. Scambia G, Ranelletti FO, Benedetti Panici P, Piantelli M, Bonanno G, De Vincenzo R, Ferrandina C, Maggiano N, Capelli A, Mancuso S: Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic antiproliferative activity with cis-diamminedichloroplatinum(II). Gynecol Oncol 45: 13-19, 1992.
8. Teofili L, Pierelli L, Iovino MS, Leone G, Scambia G, De Vincenzo R. Benedetti Panici P, Menichella G, Macri F, Piantelli M, Ranelletti FO, Larocca LM: The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leuk Res 16: 497-502, 1992.
9. Scambia G, Ranelletti FO, Panici PB, DeVincenzo R, Ferrandina C, Piantelli M, Bussa S, Rumi C, Cianfriglia M and Mancuso S: Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmocol 34: 459-64, 1994.
10. Chieli E, Romiti N, Cervelli F, Tongiani R: Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci 57: 1741-1751, 1995.
11. Shapiro AB and Ling V: Effect of quercetin on Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochem Pharmacol 53: 587-596, 1997
12. Shapiro AB and Ling V: Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. Eur J Biochem 250: 130-137, 1997.
13. Phang JM, Poore CM, Lopaczynska J, Yeh GC: Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53: 5977-5981, 1993.
14. Slevin ML: The clinical pharmacology of etoposide. Cancer 67: 319-329, 1991.
15. Leu, BL and Huang JD: Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol 35: 432-436, 1995
16. Product information: PMI Feeds, Inc. St. Louis, MO, USA, 1996.
17. Product information: Research Diets, Inc. New Brunswick, NJ, USA, 1995.
18. Chow D and Shah, J: Stability-indicating high-performance liquid chromatography of etoposide at various pH conditions using a reversed-phase octyl column. J Chromatogr 396: 217-223, 1987
19. Sasaki I, Tanaka K, Fujita T, Murakami M, Yamamoto A, Muranishi S: Intestinal absorption of azetirelin, a new thyrotropin-releasing hormone (TRH) analogue. II. In situ and in vitro absorption characteristics of azetirelin from the rat intestine. Biol Pharm Bulletin 18: 976-979, 1995.
20. Critchfield JW, Welsh CJ, Phang JM, Yeh GC: Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotcin as a putative mechanism. Biochem Pharmacol 48: 1437-1445, 1994.
21. Schested M, Friche E, Jensen PB, Demant EJ: Relationship of VP-16 to the classical multidrug resistance phenotype. Cancer Res 52: 2874-2879, 1992.
22. Drori, S, Eytan GD, Assaraf YG: Potentiation of anticancer drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem 228: 1020-1029, 1995.